J
John M. Buatti
Researcher at University of Iowa
Publications - 329
Citations - 17539
John M. Buatti is an academic researcher from University of Iowa. The author has contributed to research in topics: Radiation therapy & Radiosurgery. The author has an hindex of 60, co-authored 312 publications receiving 14428 citations. Previous affiliations of John M. Buatti include University of Arizona & Archer.
Papers
More filters
Journal ArticleDOI
3D Slicer as an image computing platform for the Quantitative Imaging Network.
Andriy Fedorov,Reinhard Beichel,Jayashree Kalpathy-Cramer,Julien Finet,Jean-Christophe Fillion-Robin,Sonia Pujol,Christian Bauer,Dominique Jennings,Fiona M. Fennessy,Milan Sonka,John M. Buatti,Stephen R. Aylward,James V. Miller,Steve Pieper,Ron Kikinis +14 more
TL;DR: An overview of 3D Slicer is presented as a platform for prototyping, development and evaluation of image analysis tools for clinical research applications and the utility of the platform in the scope of QIN is illustrated.
Journal ArticleDOI
A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis
Richard M. Auchter,John Lamond,Eben Alexander,John M. Buatti,Rick Chappell,William A. Friedman,Timothy J. Kinsella,Allan B. Levin,William R. Noyes,Christopher J. Schultz,Jay S. Loeffler,Minesh P. Mehta +11 more
TL;DR: The RS in conjunction with WBRT for single brain metastasis can produce substantial functional survival, especially in patients with good performance status and without extracranial metastasis, which strongly suggest that a randomized trial to compare RS with surgery is warranted.
Journal ArticleDOI
A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases.
Penny K. Sneed,John H. Suh,Steven J. Goetsch,Seema N Sanghavi,Rick Chappell,John M. Buatti,William F. Regine,Eduardo Weltman,Vernon King,John C. Breneman,Paul W. Sperduto,Minesh P. Mehta +11 more
TL;DR: Omission of up-front WBRT does not seem to compromise length of survival in patients treated with RS for newly diagnosed brain metastases, and there was no survival difference comparing RS alone initially to RS + up- front W BRT.
Journal ArticleDOI
O2⋅− and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate
Joshua D. Schoenfeld,Zita A. Sibenaller,Kranti A. Mapuskar,Brett A. Wagner,Kimberly L. Cramer-Morales,Muhammad Furqan,Sonia Sandhu,Thomas L. Carlisle,Mark C. Smith,Taher Abu Hejleh,Daniel J. Berg,Jun Zhang,John Keech,Kalpaj R. Parekh,Sudershan K. Bhatia,Varun Monga,Kellie L. Bodeker,Logan Ahmann,Sandy Vollstedt,Heather Brown,Erin P. Shanahan Kauffman,Mary E. Schall,Raymond J. Hohl,Gerald H. Clamon,Jeremy D.W. Greenlee,Matthew A. Howard,Michael K. Schultz,Brian J. Smith,Dennis P. Riley,Frederick E. Domann,Joseph J. Cullen,Garry R. Buettner,John M. Buatti,Douglas R. Spitz,Bryan G. Allen +34 more
TL;DR: It is shown that alterations in cancer cell mitochondrial oxidative metabolism resulting in increased levels of O2⋅- and H2O2 are capable of disrupting intracellular iron metabolism, thereby selectively sensitizing non-small-cell lung cancer and glioblastoma cells to ascorbate through pro-oxidant chemistry involving redox-active labile iron and H 2O2.
Journal ArticleDOI
Benign meningiomas: Primary treatment selection affects survival
Kellie S. Condra,John M. Buatti,William M. Mendenhall,William A. Friedman,Robert B. Marcus,Albert L. Rhoton +5 more
TL;DR: Benign meningiomas are well managed by TE or SE+RT and atypical pathologic features predict a poorer outcome, suggesting possible benefit from more aggressive treatment.